ClinicalTrials.Veeva

Menu

Emotion Regulation Group Study (EmoReg)

C

Camille Nemitz Piguet

Status

Enrolling

Conditions

Emotional Dysfunction
Borderline Personality Disorder

Treatments

Behavioral: Emotion regulation group

Study type

Interventional

Funder types

Other

Identifiers

NCT05734677
2021-01883

Details and patient eligibility

About

A clinical trial to evaluate the effects of an eight-week emotion regulation group intervention designed for adolescents (16-20 years old) on the levels of emotion dysregulation both self-reported by the adolescent and reported by his/her parent/caregiver (pre-post comparison). The long-term effect will also be measured at a third-time point, three months after the end of the intervention. The intervention will consist of 90-minute sessions once a week for 8 weeks, in groups of eight participants. The intervention proposed for this study is an adaptation from different interventions already in use for adolescents in clinical practice, such as Dialectical Behavior Therapy (DBT), Mentalization-Based Treatment (MBT) and Mindfulness-Based Intervention (MBI).

Enrollment

56 estimated patients

Sex

All

Ages

16 to 20 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Aged between 16 to 20 years old.
  • > 4 criteria of borderline symptoms (out of the 9 listed in the DSM-5) including emotional liability
  • French speaking
  • Availability during the whole study
  • Willingness in participating to the intervention and the research
  • Informed consent read and signed

Exclusion criteria

  • Current hospitalization
  • Psychotic disorder
  • Severe and persistent substance addiction
  • Antisocial personality disorder
  • Inability to participate in group sessions
  • Current pregnancy
  • Non-French speaking
  • Previous enrolment into the current study

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

56 participants in 1 patient group

psychotherapeutic intervention with class risk A (low risk, no invasive procedure)
Experimental group
Description:
an eight-week emotion regulation group intervention
Treatment:
Behavioral: Emotion regulation group

Trial contacts and locations

1

Loading...

Central trial contact

Camille Piguet

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems